![Jaap Goudsmit](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaap Goudsmit
Founder at
Leyden Laboratories B.V.
Profile
Jaap Goudsmit is the founder of Leyden Laboratories BV, founded in 2020, where the title held is Chief Scientific Officer.
Current jobs include Director-Emeritus at International AIDS Vaccine Initiative, Inc., Professor at Academisch Medisch Centrum since 1989, Member at New York University, and Professor at the University of Amsterdam since 1989.
Former jobs include Chairman at AIDS Foundation Houston, Inc., Chief Scientific Officer & Member-Management Board at Crucell NV from 2010 to 2012, and Senior Vice President at Vaccine Research International Plc from 2001 to 2002.
Education includes a doctorate from the University of Amsterdam.
Jaap Goudsmit active positions
| Companies | Position | Start |
|---|---|---|
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1989 |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Academisch Medisch Centrum
 Academisch Medisch Centrum Hospital/Nursing ManagementHealth Services Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals | Corporate Officer/Principal | 01/01/1989 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Corporate Officer/Principal | - |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Founder | 01/01/2020 |
Former positions of Jaap Goudsmit
| Companies | Position | End |
|---|---|---|
Vaccine Research International Plc
 Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Working towards further clinical trials to examine the potential of vaccine SA75 to prevent staphylococcal infections in hospital patients and the wider community. | Corporate Officer/Principal | 01/07/2002 |
AIDS Foundation Houston, Inc.
 AIDS Foundation Houston, Inc. Hospital/Nursing ManagementHealth Services Provides housing and nursing care for the sick | Chairman | - |
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Chief Tech/Sci/R&D Officer | - |
Training of Jaap Goudsmit
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Develops, produces and markets vaccines, proteins and antibodies | Health Technology |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Academisch Medisch Centrum
Academisch Medisch Centrum Hospital/Nursing ManagementHealth Services Operates as a medical center and provides scientific research & education services for next generation of healthcare professionals | Health Services |
AIDS Foundation Houston, Inc.
AIDS Foundation Houston, Inc. Hospital/Nursing ManagementHealth Services Provides housing and nursing care for the sick | Health Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaccine Research International Plc
Vaccine Research International Plc Miscellaneous Commercial ServicesCommercial Services Working towards further clinical trials to examine the potential of vaccine SA75 to prevent staphylococcal infections in hospital patients and the wider community. | Commercial Services |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Health Technology |
- Stock Market
- Insiders
- Jaap Goudsmit
Choose MarketScreener 
